1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals, Inc. XNAS: REGN

Regeneron Pharmaceuticals, Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet ag...

Read More
567.22 3.42 (0.61%)
52.02% Fall from 52W High
996.3K
XNAS Volume

XNAS 04 Sep, 2025 4:17 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Regeneron Pharmaceuticals, Inc. is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
43.5 / 100
Momentum Score
Technically Neutral
42.8 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
717
1Yr Price target upside is 26%
24 analysts

9

S

6

W

1

O

2

T

SWOT Analysis

Regeneron Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..